Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

9amHealth vs NowPatient

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.6

9amHealth

Best for Insured patients wanting branded GLP-1s within a full cardiometabolic care program
★★★3.8

Starting at $149/mo

Branded GLP-1WegovyZepboundSaxenda
Visit 9amHealth
6.8

NowPatient

Best for Brand-name GLP-1 access without a compounded route
★★★☆☆3.4

Starting at $1069/mo

BrandFree Consultation
Visit NowPatient

Side-by-Side Comparison

Feature9amHealthNowPatient
Overall Score7.6/106.8/10
Starting Price$149/mo$1069/mo
Editorial Rating3.8 ★ /53.4 ★ /5
Features7 features2 features
States Available00
Compounded
Brand Name✓ Yes✓ Yes
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

9amHealth

Pros

  • Prescribes FDA-approved branded GLP-1s (Wegovy, Zepbound, Saxenda)
  • $149/month membership or free when covered by insurance
  • Membership includes specialists, labs, devices, and medications
  • Board-certified obesity specialists (DABOM), endocrinologists, dietitians, PharmDs
  • Helps navigate insurance approvals; employer and state-plan partnerships
  • Home lab draws available in some areas
  • Cardiometabolic whole-body care beyond weight loss

Cons

  • Medication coverage and GLP-1 access depend on insurance and BMI criteria
  • State availability not enumerated on the public site
  • Branded GLP-1s can be costly without insurance coverage
  • Pricing for medications not transparently listed

NowPatient

Pros

  • Free telehealth consultation — you only pay for the medication
  • Brand-name Mounjaro, Wegovy injection, Wegovy oral tablet, and Saxenda all available
  • One of the few platforms offering Wegovy in both injection and oral pill form
  • No compounded options — every drug is FDA-approved brand-name

Cons

  • Cash-pay pricing tracks full brand list price (~$1,000–$1,350/mo)
  • No compounded semaglutide or tirzepatide (usually the cheaper route)
  • State availability determined during intake, not shown upfront
  • Does not offer Foundayo (orforglipron)

Our Verdict

Winner: 9amHealthScore: 7.6/10

9amHealth edges out NowPatient with a higher overall score of 7.6/10 and is particularly strong for Insured patients wanting branded GLP-1s within a full cardiometabolic care program. NowPatient remains a solid alternative, especially if you're looking for Brand-name GLP-1 access without a compounded route.

Glossary references

Key terms in this article, linked to their canonical definitions.

Related comparisons

Continue exploring 9amHealth and NowPatient head-to-heads in the same category.

Or see the full category ranking.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.